Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Management Change

Gennex Laboratories Management Change

Gennex Laboratories announced the appointment of Mr. Dipankar Dasgupta as Independent Director, replacing Mr. Amudala Sreeramulu Nageswar Rao, effective October 1, 2026.

Source

BSE filing, NSE: GENNEX. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Gennex Laboratories Ltd: key numbers

Share price
₹9.10
Market cap
₹221.1 Cr
Revenue (annual)
₹172.7 Cr
Net profit (annual)
₹20.98 Cr
P/E (TTM)
9.3×Sector 46.1×
Promoter holding
23.63%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Gennex Laboratories Ltd

All →

Other management change announcements

All →